THE REQUIREMENT OF LOW-CALCIUM DIALYSATE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS RECEIVING CALCIUM-CARBONATE AS A PHOSPHATE BINDER

被引:0
作者
CHENG, IKP
LU, HB
CHAN, CY
CHENG, SW
ROBINSON, JD
TAM, SCF
LO, WK
CHEUNG, WC
机构
[1] UNIV HONG KONG,CLIN BIOCHEM UNIT,POKFULAM,HONG KONG
[2] TUNG WAH HOSP,RENAL UNIT,HONG KONG,HONG KONG
关键词
PERITONEAL DIALYSIS; CALCIUM CARBONATE; LOW CALCIUM DIALYSATE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In the present study we investigated the requirement of low calcium dialysate in 35 patients on continuous ambulatory peritoneal dialysis (CAPD) receiving calcium carbonate as the sole phosphate binder over a 12-month period. Patients with corrected serum calcium greater-than-or-equal-to 2.85 mmol/L after switching to oral calcium carbonate were given 1 to 3 2-litre exchanges of 2.5 mEq/L calcium dialysate. Serum phosphate level dropped from the pretreatment value of 2.95 +/- 0.62 to a level of between 1.70 +/- 0.41 to 2.03 +/- 0.44 mmol/L 2 weeks after therapy. Corrected serum calcium level increased significantly from 2 weeks onwards. Serum alkaline phosphatase rose initially at 2 and 6 weeks and decreased from 3 months onwards. Serum parathyroid hormone level dropped significantly from a mean pretreatment level of 569 to 320 pg/ml after 12 months (p <0.001). Serum aluminum decreased significantly from a mean of 1.04 to 0.65 umol/L (p <0.01). Daily calcium carbonate requirement fluctuated but tended to increase till 8 months and plateaued and ranged from 2.61 +/- 0.57 to 3.98 +/- 2.11 gm. The daily requirement of low calcium dialysate followed a similar trend with approximately three-quarters of patients ultimately requiring at least 1 bag of low calcium dialysate. Eight patients did not require low calcium dialysate. Patients who required low calcium dialysate were significantly older, had a significantly lower pretreatment serum parathyroid hormone and higher serum aluminum levels than those who did not. It was concluded that calcium carbonate is an effective phosphate binder in patients on CAPD and its use prevents aluminum accumulation in the body but the concomitant use of low calcium dialysate is required in the majority of patients receiving such treatment to prevent the development of hypercalcemia. This is especially so in patients with a lower degree of bone turnover.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 14 条
[1]   ALUMINUM INTOXICATION FROM ALUMINUM-CONTAINING PHOSPHATE BINDERS IN CHILDREN WITH AZOTEMIA NOT UNDERGOING DIALYSIS [J].
ANDREOLI, SP ;
BERGSTEIN, JM ;
SHERRARD, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (17) :1079-1084
[2]  
CHAN TM, 1992, NEPHROL DIAL TRANSPL, V7, P835
[3]  
COBURN JW, 1991, KIDNEY, P2036
[4]   CALCIUM ACETATE CONTROL OF SERUM PHOSPHORUS IN HEMODIALYSIS-PATIENTS [J].
EMMETT, M ;
SIRMON, MD ;
KIRKPATRICK, WG ;
NOLAN, CR ;
SCHMITT, GW ;
CLEVELAND, MV .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (05) :544-550
[5]  
HUTCHISON A J, 1991, Journal of the American Society of Nephrology, V2, P611
[6]   OPTIMUM DIALYSATE CALCIUM CONCENTRATION DURING MAINTENANCE HEMODIALYSIS [J].
JOHNSON, WJ .
NEPHRON, 1976, 17 (04) :241-258
[7]  
KWONG MBL, 1987, PERITON DIALYSIS INT, V7, P85
[8]  
MARTIS L, 1989, PERITON DIALYSIS INT, V9, P325
[9]   ETIOLOGY OF HYPERCALCEMIA IN HEMODIALYSIS-PATIENTS ON CALCIUM-CARBONATE THERAPY [J].
MERIC, F ;
YAP, P ;
BIA, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) :459-464
[10]   EFFECTS OF ORAL CALCIUM-CARBONATE ON CONTROL OF SERUM PHOSPHORUS AND CHANGES IN PLASMA ALUMINUM LEVELS AFTER DISCONTINUATION OF ALUMINUM-CONTAINING GELS IN CHILDREN RECEIVING DIALYSIS [J].
SALUSKY, IB ;
COBURN, JW ;
FOLEY, J ;
NELSON, P ;
FINE, RN .
JOURNAL OF PEDIATRICS, 1986, 108 (05) :767-770